Cadrenal Therapeutics, Inc. (CVKD): Shareholders' Equity
$2.74M
As of 2025-12-31
$4.09M
As of 2026-06-30
| Period ended | Shareholders' Equity | Change YoY | Source filing |
|---|---|---|---|
| 2025-12-31 | $2.74M | -63.2% | 2026-03-31, Balance as of period end |
| 2024-12-31 | $7.44M | -3.3% | 2026-03-31, Balance as of period end |
| 2023-12-31 | $7.69M | n/m | 2025-03-13, Balance as of period end |
| 2022-12-31 | -$5.55M | n/a | 2024-03-11, Balance as of period end |
Shareholders' Equity at similar companies
| Company | Year ended | Shareholders' Equity | Change YoY |
|---|---|---|---|
| Cadrenal Therapeutics, Inc. (CVKD) | 2025-12-31 | $2.74M | -63.2% |
| Lexaria Bioscience Corp. (LEXX) | 2025-08-31 | $2.99M | -62.8% |
| Pulmatrix, Inc. (PULM) | 2025-12-31 | $3.81M | -57.4% |
| International Stem Cell Corp (ISCO) | 2025-12-31 | -$4.06M | n/m |
| Bio-Path Holdings, Inc. (BPTH) | 2024-12-31 | $154.0K | -65.1% |
| Azitra, Inc. (AZTR) | 2025-12-31 | $3.80M | -33.3% |
| Enveric Biosciences, Inc. (ENVB) | 2025-12-31 | $4.18M | +162.3% |
| Protagenic Therapeutics, Inc.\new (PTIX) | 2026-03-31 | $2.62M | n/m |
| Petros Pharmaceuticals, Inc. (PTPI) | 2025-12-31 | $2.87M | n/m |
Compare CVKD, LEXX, PULM, ISCO side by side · Screen every company in Pharmaceutical Preparations ↗